Paolo Vigneri

8.8k total citations · 2 hit papers
156 papers, 5.6k citations indexed

About

Paolo Vigneri is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Paolo Vigneri has authored 156 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 45 papers in Molecular Biology and 42 papers in Hematology. Recurrent topics in Paolo Vigneri's work include Chronic Myeloid Leukemia Treatments (41 papers), Chronic Lymphocytic Leukemia Research (32 papers) and Thyroid Cancer Diagnosis and Treatment (20 papers). Paolo Vigneri is often cited by papers focused on Chronic Myeloid Leukemia Treatments (41 papers), Chronic Lymphocytic Leukemia Research (32 papers) and Thyroid Cancer Diagnosis and Treatment (20 papers). Paolo Vigneri collaborates with scholars based in Italy, United States and United Kingdom. Paolo Vigneri's co-authors include Riccardo Vigneri, Francesco Frasca, Laura Sciacca, Giuseppe Pandini, Jean Y. J. Wang, Livia Manzella, Pasqualino Malandrino, Stefania Stella, Michele Massimino and Marco A. Pierotti and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Paolo Vigneri

147 papers receiving 5.5k citations

Hit Papers

Diabetes and cancer 2009 2026 2014 2020 2009 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diabetes and cancer
    2009 803 citations Paolo Vigneri, Francesco Frasca et al. Endocrine Related Cancer profile →
  2. AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
    2021 160 citations Federica Martorana, Gianmarco Motta et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Vigneri Italy 40 2.5k 1.8k 1.5k 977 773 156 5.6k
Angela Greco Italy 43 3.2k 1.3× 1.9k 1.0× 1.3k 0.8× 772 0.8× 439 0.6× 120 6.3k
Mercedes Robledo Spain 44 2.2k 0.9× 1.2k 0.7× 2.2k 1.5× 2.2k 2.3× 188 0.2× 195 6.0k
Nancy A. Dawson United States 33 945 0.4× 1.3k 0.7× 545 0.4× 782 0.8× 658 0.9× 145 4.3k
Iris Goldberg Israel 43 2.3k 0.9× 937 0.5× 521 0.3× 664 0.7× 494 0.6× 121 6.0k
Yan Wu China 40 4.6k 1.8× 2.7k 1.5× 182 0.1× 1.7k 1.7× 804 1.0× 126 7.5k
Jacques Bonneterre France 44 1.9k 0.8× 5.1k 2.8× 816 0.5× 2.8k 2.8× 202 0.3× 257 8.0k
Marco M. Gottardis United States 46 3.4k 1.3× 1.7k 1.0× 1.5k 0.9× 1.2k 1.3× 130 0.2× 134 6.5k
Takeshi Ueda Japan 32 1.8k 0.7× 1.2k 0.7× 430 0.3× 899 0.9× 138 0.2× 156 4.2k
Kyriakos P. Papadopoulos United States 47 4.3k 1.7× 3.8k 2.1× 181 0.1× 1.2k 1.3× 636 0.8× 324 8.1k
Jun Gu China 28 1.6k 0.6× 723 0.4× 409 0.3× 915 0.9× 153 0.2× 144 3.2k

Countries citing papers authored by Paolo Vigneri

Since Specialization
Citations

This map shows the geographic impact of Paolo Vigneri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Vigneri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Vigneri more than expected).

Fields of papers citing papers by Paolo Vigneri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Vigneri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Vigneri. The network helps show where Paolo Vigneri may publish in the future.

Co-authorship network of co-authors of Paolo Vigneri

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Vigneri. A scholar is included among the top collaborators of Paolo Vigneri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Vigneri. Paolo Vigneri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palleschi, Michela, Federica Martorana, Giacomo Barchiesi, et al.. (2025). Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2− Breast Cancer: A Systematic Review. Cancers. 17(17). 2940–2940.
2.
Stagno, Fabio, Stefania Stella, Salvatore Leotta, et al.. (2025). No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level. International Journal of Molecular Sciences. 26(5). 1840–1840.
3.
Schettini, Francesco, Elisa Rubio-García, Rubén López-Aladid, et al.. (2024). Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications. Cancer Treatment Reviews. 130. 102816–102816. 9 indexed citations
4.
Marıno, Andrea, Giuliana Pavone, Federica Martorana, et al.. (2024). Navigating the Nexus: HIV and Breast Cancer—A Critical Review. International Journal of Molecular Sciences. 25(6). 3222–3222. 10 indexed citations
5.
Pavone, Giuliana, Andrea Marıno, Lucia Motta, et al.. (2024). Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review. International Journal of Molecular Sciences. 25(19). 10358–10358. 11 indexed citations
6.
Rossi, Lorenzo, et al.. (2023). The optimal timing between neoadjuvant therapy and surgery of breast cancer: A brief systematic review of the literature. Critical Reviews in Oncology/Hematology. 183. 103921–103921. 1 indexed citations
7.
8.
Pennisi, Maria Stella, Sandra Di Gregorio, Elena Tirrò, et al.. (2023). Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports. SHILAP Revista de lepidopterología. 15(2). 317–324. 1 indexed citations
9.
Broggi, Giuseppe, Elena Tirrò, Antonietta Arcella, et al.. (2022). Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor. Neuropathology. 42(3). 169–180. 1 indexed citations
10.
Pavone, Giuliana, Chiara Romano, Federica Martorana, et al.. (2022). Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature. Diagnostics. 12(9). 2160–2160. 2 indexed citations
11.
Romano, Chiara, Sandra Di Gregorio, Maria Stella Pennisi, et al.. (2022). Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis. Molecular Biology Reports. 49(9). 9059–9064. 3 indexed citations
12.
Vella, Veronica, Alessandro La Ferlita, Michele Pellegrino, et al.. (2021). Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells. Cells. 10(11). 3145–3145. 17 indexed citations
13.
Pavone, Giuliana, Lucia Motta, Federica Martorana, Gianmarco Motta, & Paolo Vigneri. (2021). A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid Tumors. Molecules. 26(23). 7294–7294. 23 indexed citations
14.
Broggi, Giuseppe, Lucia Salvatorelli, Davide Barbagallo, et al.. (2021). Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas. Cancers. 13(9). 2086–2086. 35 indexed citations
15.
Massimino, Michele, Paolo Vigneri, Stefania Stella, et al.. (2021). Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells. Journal of Clinical Medicine. 10(23). 5606–5606. 11 indexed citations
16.
Stella, Stefania, Eva Barragán, Santa Errichiello, et al.. (2019). The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias. International Journal of Molecular Sciences. 20(24). 6106–6106. 10 indexed citations
17.
Malandrino, Pasqualino, Marco Russo, A. Ronchi, et al.. (2019). Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas. Thyroid. 30(2). 290–299. 14 indexed citations
18.
Stella, Stefania, Elena Tirrò, Enrico Conte, et al.. (2013). Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs. Molecular Cancer Therapeutics. 12(6). 1085–1098. 51 indexed citations
19.
Bellodi, Cristian, Mattia Ronchetti, Sara Galavotti, et al.. (2013). Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells (vol 119, pg 1109, 2009). UCL Discovery (University College London).
20.
Vigneri, Paolo, Francesco Frasca, Laura Sciacca, Giuseppe Pandini, & Riccardo Vigneri. (2009). Diabetes and cancer. Endocrine Related Cancer. 16(4). 1103–1123. 803 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Greco Breakdown of academic impact, for papers by Mercedes Robledo Breakdown of academic impact, for papers by Nancy A. Dawson Breakdown of academic impact, for papers by Iris Goldberg Breakdown of academic impact, for papers by Yan Wu Breakdown of academic impact, for papers by Jacques Bonneterre Breakdown of academic impact, for papers by Marco M. Gottardis Breakdown of academic impact, for papers by Takeshi Ueda Breakdown of academic impact, for papers by Kyriakos P. Papadopoulos Breakdown of academic impact, for papers by Jun Gu
Rankless by CCL
2026